Biofil Chemicals & Pharmaceuticals Ltd.
| BSE: 524396 | Sector: Health care |
| NSE: BIOFILCHEM | ISIN Code: INE829A01014 |
| BSE 00:00 | 24 Apr | Biofil Chemicals & Pharmaceuticals Ltd |
| NSE 05:30 | 01 Jan | Biofil Chemicals & Pharmaceuticals Ltd |
| OPEN | 13.03 |
| PREVIOUS CLOSE | 12.41 |
| VOLUME | 5 |
| 52-Week high | 17.90 |
| 52-Week low | 3.86 |
| P/E | 18.35 |
| Mkt Cap.(Rs cr) | 21 |
| Buy Price | 13.03 |
| Buy Qty | 9000.00 |
| Sell Price | 7.75 |
| Sell Qty | 99.00 |
Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) - Announcements
-
Biofil Chemicals & Pharmaceuticals Ltd Closure of Trading Window
31/03/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
17/02/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Continual Disclosure Under Sub-Para 2 Of Para B Of Part A Of Schedule III Of The SEBI(LODR) Regulati
15/02/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Un-Audited Financial Results For The Quarter And Nine Month Ended 31St December 2019
14/02/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd - Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Ni
14/02/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
05/02/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Result For The Quarte
04/02/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Updation Of Particulars In Respect Of Corporate Information Of The Company.
03/02/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
24/01/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
24/01/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2019
15/01/2020 | bse
-
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
06/01/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04/01/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2019
04/01/2020 | bse
-
Biofil Chemicals & Pharmaceuticals Ltd Closure of Trading Window
31/12/2019 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
27/12/2019 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Disclosures Of Related Party Transactions Pursuant To Regulation 23(9) Of Securities And Exchange Bo
02/12/2019 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
16/11/2019 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Submission Of Standalone Un Audited Financial Results For The Quarter As Well As Half Year Ended 3
14/11/2019 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Outcome Of Board Meeting And Submission Of Standalone Unaudited Financial Results For The Quarter A
14/11/2019 | bse |
Downlaod PDF
Quick Links for Biofil Chemicals & Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
